Literature DB >> 3614988

Rate of Leishmania-induced skin-lesion development in rodents depends on the site of inoculation.

C E Kirkpatrick, T J Nolan, J P Farrell.   

Abstract

Regional differences in the response of mice to infection with three strains of dermotropic Leishmania spp. were shown for skin covering the trunk. Lesions tended to appear earlier and to grow more rapidly on sites over the caudal half of the body than the cranial half, and caudal lesions were more likely than cranial ones to result in metastatic disease in susceptible strains of mice. Site-related variations in lesion development were observed in different strains of mice as well as in golden hamsters. The effect of these regional differences on the development of some parasite-specific, immunological reactions was examined, as were parasite thermosensitivity and location-related variations in host skin temperature as possible explanations.

Entities:  

Mesh:

Year:  1987        PMID: 3614988     DOI: 10.1017/s0031182000055803

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  9 in total

1.  Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone.

Authors:  B Guy; S Fourage; C Hessler; V Sanchez; M J Millet
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

2.  Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.

Authors:  Flavia L Ribeiro-Gomes; Eric Henrique Roma; Matheus B H Carneiro; Nicole A Doria; David L Sacks; Nathan C Peters
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

3.  Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection.

Authors:  Khaled S Tabbara; Nathan C Peters; Farhat Afrin; Susana Mendez; Sylvie Bertholet; Yasmine Belkaid; David L Sacks
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.

Authors:  P C Melby; Y Z Yang; J Cheng; W Zhao
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

5.  A Mouse Model of Ulcerative Cutaneous Leishmaniasis by Leishmania (Viannia) panamensis to Investigate Infection, Pathogenesis, Immunity, and Therapeutics.

Authors:  Natalia Muñoz-Durango; Alexander Gómez; Natalia García-Valencia; Miguel Roldán; Marcela Ochoa; David E Bautista-Erazo; José R Ramírez-Pineda
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

6.  A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection.

Authors:  Naomi E Aronson; Glenn W Wortmann; William R Byrne; Robin S Howard; Wendy B Bernstein; Mary A Marovich; Mark E Polhemus; In-Kyu Yoon; Kelly A Hummer; Robert A Gasser; Charles N Oster; Paul M Benson
Journal:  PLoS Negl Trop Dis       Date:  2010-03-09

7.  The site of Leishmania major infection determines disease severity and immune responses.

Authors:  Tracey M Baldwin; Colleen Elso; Joan Curtis; Lynn Buckingham; Emanuela Handman
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response.

Authors:  G S Nabors; J P Farrell
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c mice.

Authors:  Hamid Mahmoudzadeh-Niknam; Ghader Khalili; Firoozeh Abrishami; Ali Najafy; Vahid Khaze
Journal:  Korean J Parasitol       Date:  2013-02-18       Impact factor: 1.341

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.